Article Information
- January 21, 2021.
Article Versions
- Version 1 (January 4, 2021 - 07:37).
- Version 2 (January 7, 2021 - 09:42).
- You are viewing Version 3, the most recent version of this article.
REVISION SUMMARY
Conflict of interest The manufacturer had no role to play in the study. The authors have no conflict of interests to disclose pertaining to this study.
In the abstract and introduction it is stated that the Panbio is FDA approved. This is incorrect, as the binax is FDA approved but not the Panbio. We have changed FDA approved to Health Canada approved to solve this error.
Author Information
- William Stokes, MD1,2,3,*,
- Byron M. Berenger, MD.1,4,
- Danielle Portnoy6,
- Brittney Scott, PhD6,
- Jonas Szelewicki6,
- Takshveer Singh5,
- Allison A. Venner, PhD1,4,
- LeeAnn Turnbull1,
- Kanti Pabbaraju1,
- Sandy Shokoples1,
- Anita A. Wong1,
- Kara Gill1,
- Tracy Guttridge1,
- Dustin Proctor, PhD1,4,
- Jia Hu, MD7,8 and
- Graham Tipples, PhD1,2,9
- 1Alberta Precision Laboratories, Alberta, Canada
- 2Department of Pathology and Laboratory Medicine, University of Alberta, Alberta, Canada
- 3Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta
- 4Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
- 5Cumming School of Medicine, University of Calgary, Calgary, Alberta
- 6Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta
- 7Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
- 8Public Health, Alberta Health Services, Alberta, Canada
- 9Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada
- ↵*Corresponding author: William Stokes, William.Stokes{at}AlbertaPrecisionLabs.ca